Adding Citius (CTXR) $0.55 to Watch List.

Best Presentation at Dawson James Conference. We attended the Dawson James Conference on October 29th, which had over 20 medtech and biotech companies. The two...
Internet Stock Review

What We’re Watching.

“Biotech, Beverages and Bears - Oh My!” — Daniel K. McMahon Headlines this week from winners in the past and just maybe, from some major winners...

True Nature (TNTY) Readies Launch of Mitesco: “The Medtech Incubator”

ATLANTA, GA, Nov. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- True Nature Holding, Inc. (OTCQB: TNTY, “the Company”) today announced that is has...

Medtech Incubator in Final Stages of Launch.

TrueNature (TNTY) Has Spent the Past Year Gearing Up. News of a Launch and First Incubation Effort Could be Around the Corner and Attract...

Emerald Organic (EMOR) to License Therapeutics Portfolio from Amarantus Bioscience Holdings (AMBS).

The portfolio includes treatments for Alzheimer’s disease, ADHD, Parkinson’s disease, vision loss and severe burns. Amarantus to receive Emerald Organics Preferred Stock for the...
Dyadic, Biotech Stock Review

Dyadic (DYAI) $7.00 Called a ‘Gamechanger’ – Gets $14 Price Target.

Highly Respected Wall Street Analyst Jason Kolbert Issues $14.00 Price Target On Dyadic. Analyst Take: "Potential to be Revolutionary. Dyadic’s C1 shows potential in...
Dyadic

Investor Presentation Slides From Dyadic (DYA) $6.40.

Really, How Do We Do It? Live Short Term Chart INVESTOR PRESENTATION LONGER TERM CHART Client, see published reports for disclosure and disclaimer details.
Mitesco

Healthcare Incubators and Wearable Devices.

Originally published August 22, 2019 The Global Wearable Devices Market is expected to exceed more than $51.50 billion by 2022 at a CAGR of 15...

Dawson James Securities Announces 5th Annual Small Cap Growth Conference.

BOCA RATON, Fla., Sept. 25, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Dawson James Securities, Inc. (“Dawson”), a full-service boutique investment banking firm focused on emerging...

Latest article

Jeffrey Gundlach: Reckoning is Coming.

Jeffrey Edward Gundlach is a businessman, fund manager, and philanthropist. He is the founder of DoubleLine Capital, an investment firm. On 11 November 2020, Gundlach remarked in an interview with...

Who’s the Next Eric Sprott?

Eric Sprott, on Who is the Next Eric Sprott! To say Eric Sprott has left a legendary mark on the world of mining investment would...

Perpetua (PPTA) Raises $300 Million.

Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...